SE423233B - Analogiforfarande for framstellning av 1,2,3,4-tetrahydroisokinoliner - Google Patents
Analogiforfarande for framstellning av 1,2,3,4-tetrahydroisokinolinerInfo
- Publication number
- SE423233B SE423233B SE7608453A SE7608453A SE423233B SE 423233 B SE423233 B SE 423233B SE 7608453 A SE7608453 A SE 7608453A SE 7608453 A SE7608453 A SE 7608453A SE 423233 B SE423233 B SE 423233B
- Authority
- SE
- Sweden
- Prior art keywords
- tetrahydroisokinolines
- preparation
- analogy procedure
- analogy
- procedure
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/30—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
- C07D257/06—Five-membered rings with nitrogen atoms directly attached to the ring carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
- C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
- C07D285/135—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB31570/75A GB1553230A (en) | 1975-07-28 | 1975-07-28 | 1 - aminomethyl - 6,7-dihydroxy - 1,2,3,4-tetrahydroisoquinolines and the preparation thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE7608453L SE7608453L (sv) | 1977-01-29 |
| SE423233B true SE423233B (sv) | 1982-04-26 |
Family
ID=10325102
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7608453A SE423233B (sv) | 1975-07-28 | 1976-07-26 | Analogiforfarande for framstellning av 1,2,3,4-tetrahydroisokinoliner |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US4096263A (no) |
| JP (1) | JPS5217477A (no) |
| AR (1) | AR212174A1 (no) |
| AT (1) | AT358588B (no) |
| AU (1) | AU506715B2 (no) |
| BE (1) | BE844472A (no) |
| CA (1) | CA1068276A (no) |
| CH (1) | CH623310A5 (no) |
| DE (1) | DE2633692A1 (no) |
| DK (1) | DK143750C (no) |
| ES (1) | ES450206A1 (no) |
| FR (1) | FR2319357A1 (no) |
| GB (1) | GB1553230A (no) |
| IE (1) | IE43502B1 (no) |
| IT (1) | IT1063405B (no) |
| MX (1) | MX3999E (no) |
| NL (1) | NL7608319A (no) |
| SE (1) | SE423233B (no) |
| ZA (1) | ZA764508B (no) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5734275B2 (no) * | 1973-07-30 | 1982-07-22 | ||
| US4456757A (en) * | 1981-03-20 | 1984-06-26 | Asahi Kasei Kogyo Kabushiki Kaisha | Isoquinolinesulfonyl derivatives and process for the preparation thereof |
| GB8921304D0 (en) * | 1989-09-20 | 1989-11-08 | Wyeth John & Brother Ltd | New method of treatment and heterocyclic compounds used therein |
| JP4889463B2 (ja) * | 2006-12-07 | 2012-03-07 | 株式会社椿本バルクシステム | チェーンコンベヤ |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3389140A (en) * | 1966-05-16 | 1968-06-18 | Bristol Myers Co | 1-beta-arylaminoethyl-2-methyl-6, 7-dimethoxy-1, 2, 3, 4-tetrahydroisoquinolines |
| JPS5734275B2 (no) * | 1973-07-30 | 1982-07-22 | ||
| US3963725A (en) * | 1973-07-20 | 1976-06-15 | Fujisawa Pharmaceutical Co., Ltd. | 1,2,3,4-Tetrahydroisoquinoline derivatives and the preparation thereof |
| US3994891A (en) * | 1974-12-20 | 1976-11-30 | Armour Pharmaceutical Company | Tetrahydroisoquinoline compounds |
-
1975
- 1975-07-28 GB GB31570/75A patent/GB1553230A/en not_active Expired
-
1976
- 1976-06-21 AR AR264017A patent/AR212174A1/es active
- 1976-07-21 US US05/707,271 patent/US4096263A/en not_active Expired - Lifetime
- 1976-07-23 IT IT25672/76A patent/IT1063405B/it active
- 1976-07-23 BE BE169196A patent/BE844472A/xx not_active IP Right Cessation
- 1976-07-26 SE SE7608453A patent/SE423233B/xx unknown
- 1976-07-26 DK DK336676A patent/DK143750C/da not_active IP Right Cessation
- 1976-07-27 ZA ZA764508A patent/ZA764508B/xx unknown
- 1976-07-27 DE DE19762633692 patent/DE2633692A1/de not_active Withdrawn
- 1976-07-27 ES ES450206A patent/ES450206A1/es not_active Expired
- 1976-07-27 CH CH960976A patent/CH623310A5/de not_active IP Right Cessation
- 1976-07-27 NL NL7608319A patent/NL7608319A/xx not_active Application Discontinuation
- 1976-07-27 MX MX764843U patent/MX3999E/es unknown
- 1976-07-27 IE IE1655/76A patent/IE43502B1/en unknown
- 1976-07-27 AU AU16290/76A patent/AU506715B2/en not_active Expired
- 1976-07-27 CA CA257,828A patent/CA1068276A/en not_active Expired
- 1976-07-27 AT AT552076A patent/AT358588B/de not_active IP Right Cessation
- 1976-07-27 FR FR7622896A patent/FR2319357A1/fr active Granted
- 1976-07-28 JP JP51090753A patent/JPS5217477A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| IT1063405B (it) | 1985-02-11 |
| SE7608453L (sv) | 1977-01-29 |
| GB1553230A (en) | 1979-09-26 |
| ZA764508B (en) | 1977-07-27 |
| DK143750B (da) | 1981-10-05 |
| AR212174A1 (es) | 1978-05-31 |
| AT358588B (de) | 1980-09-25 |
| CA1068276A (en) | 1979-12-18 |
| DK143750C (da) | 1982-03-29 |
| FR2319357B1 (no) | 1978-11-17 |
| ATA552076A (de) | 1980-02-15 |
| AU506715B2 (en) | 1980-01-24 |
| IE43502B1 (en) | 1981-03-11 |
| DK336676A (da) | 1977-01-29 |
| NL7608319A (nl) | 1977-02-01 |
| IE43502L (en) | 1977-01-28 |
| FR2319357A1 (fr) | 1977-02-25 |
| DE2633692A1 (de) | 1977-02-17 |
| JPS5217477A (en) | 1977-02-09 |
| CH623310A5 (no) | 1981-05-29 |
| AU1629076A (en) | 1978-02-02 |
| US4096263A (en) | 1978-06-20 |
| BE844472A (fr) | 1977-01-24 |
| MX3999E (es) | 1981-10-28 |
| ES450206A1 (es) | 1977-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE433208B (sv) | Forfarande for framstellning av fenoletrar | |
| SE431753B (sv) | Analogifprfarande for framstellning av 2-piperazinyl-6,7-dimetoxikinazoliner | |
| SE434398B (sv) | Analogiforfarande for framstellning av pyrido(2,1-b)kinazolinoner | |
| SE7603791L (sv) | Forfarande for framstellning av 17 alfa-ester-21-halogenpregnaner | |
| SE7605139L (sv) | Forfarande for framstellning av vattenupptagande cellulosaetrar | |
| SE430336B (sv) | Forbettrat forfarande for framstellning av amoxicillinfrihydrat | |
| SE7604475L (sv) | Forfarande for framstellning av 1,1,1-triaryl-alkylaminer | |
| NO150882C (no) | Analogifremgangsmaate ved fremstilling av nye 1,4-benzoksazin-derivater | |
| SE428296B (sv) | Analogiforfarande for framstellning av substituerade difonylsulfider | |
| SE427839B (sv) | Analogiforfaranden for framstellning av n-aryl-n-(1-l-4-piperidinyl)-aryl-acetamider | |
| SE419983B (sv) | Forfarande for framstellning av finkornig, fast cyanurklorid | |
| SE435510B (sv) | Analogiforfarande for framstellning av 3-fluor-6-piperazinylmorfantridiner | |
| NO146058C (no) | Analogifremgangsmaate for fremstilling av substituerte benzamider | |
| DK143757C (da) | Analogifremgangsmaade til fremstilling af 16,16-disubstituerede 3-oxoandrostener | |
| NO139555C (no) | Fremgangsmaate for fremstilling av fosgen | |
| SE428922B (sv) | Forfarande for framstellning av 13, 14-dihydro-11-dioxi-prostaglandiner | |
| SE7606116L (sv) | Forfarande for framstellning av 3-fenoxidbensaldehyder | |
| SE427841B (sv) | Analogiforfarande for framstellning av tienamycinderivat | |
| SE420999B (sv) | Framstellning av 2,4-diamino-5-bensylpyrimidiner | |
| SE7604781L (sv) | Forfarande for framstellning av diarylhydroxibutylaminer | |
| SE423233B (sv) | Analogiforfarande for framstellning av 1,2,3,4-tetrahydroisokinoliner | |
| SE7600847L (sv) | Nytt forfarande for framstellning av 8-bromtienotriazolo-1,4-diazepiner | |
| SE421793B (sv) | Analogiforfarande for framstellning naftyridinsubstituerade pyrrolderivat | |
| SE404186B (sv) | Forfarande for framstellning av cyklopropanolderivat | |
| SE427840B (sv) | Analogiforfarande for framstellning av tienamycinderivat |